Drug cheats like Dwain Chambers and David Millar will be welcomed back in to Team GB with open arms if the BOA's bylaw on lifetime bans is scrapped next week, according to former Olympic champion Jonathan Edwards.
Investment Insider: When it comes to the stock market, the Budget really doesn't matter
Sunday 25 March 2012
Surfers to take part in biggest ever clean-up of plastic packaging
Friday 23 March 2012
Around 1,000 surfers will swap their boards for rubber gloves and bags this weekend for their biggest ever clean-up of plastic packaging, drinks tins and other debris on beaches.
How new technology transformed failing school
Tuesday 20 March 2012
Richard Garner visits Essa Academy in Bolton – the cutting edge of an education revolution
Glaxo thinks big with joint Japanese vaccines venture
Saturday 03 March 2012
GlaxoSmithKline, Britain's biggest drug maker, yesterday set out plans for a joint venture with Tokyo-based Daiichi Sankyo that will make it the largest vaccines company in Japan.
Putting women on the board
Thursday 23 February 2012
While some FTSE 100 companies have already beaten the target to have one in four female directors by 2015, overall change at the top is still slow
The women who are breaking into the boardroom
Sunday 15 January 2012
Almost 100 females were made directors of top UK businesses last year. It's not equality – but it's definitely progress. Lucy Tobin reports
The business on...Olivier Bohuon, Chief executive, Smith & Nephew
Saturday 05 November 2011
Some creaky joints at Smith & Nephew?
You could say that. Olivier Bohuon was only appointed as chief executive in February after the surprise departure of the much-respected David Illingworth.
David Kuo: Don't be fearful – learn to be wise and keep going
Sunday 28 August 2011
David Kuo: Ignore the noise if you want to get ahead of the market
Sunday 31 July 2011
Investment Column: Glaxo remains a healthy bet for investors
Wednesday 27 July 2011
In a busy City week, Reckitt is set to declare a slowdown
Sunday 24 July 2011
Reckitt Benckiser, owner of Durex and Nurofen, kicks off a busy week in the City tomorrow, with interim results also due from FTSE 100 giants BP and GlaxoSmithKline.
GSK signs sport anti-doping deal
Tuesday 05 July 2011
GlaxoSmithKline has signed a deal with the World Anti-Doping Agency (Wada) to help scientists develop early detection methods for drugs that have performance-enhancing potential in sport.








